Atypical small acinar proliferation

Medical condition

Atypical small acinar proliferation

Other names| ASAP

In urologic pathology, atypical small acinar proliferation, is a collection of small prostatic glands, on prostate biopsy, whose significance is uncertain and cannot be determined to be benign or malignant.

ASAP, generally, is not considered a pre-malignancy, or a carcinoma in situ; it is an expression of diagnostic uncertainty,[1] and analogous to the diagnosis of ASCUS (atypical squamous cells of undetermined significance) on the Pap test.

## Association with adenocarcinoma

[edit]

On a subsequent biopsy, given the diagnosis of ASAP, the chance of finding prostate adenocarcinoma is approximately 40%; this is higher than if there is high-grade prostatic intraepithelial neoplasia (HGPIN).[2]

## Management

[edit]

ASAP is considered an indication for re-biopsy;[3] in one survey of urologists[4] 98% of respondents considered it a sufficient reason to re-biopsy.

## See also

[edit]

* Sensitivity

## References

[edit]

1. ^ Flury SC, Galgano MT, Mills SE, Smolkin ME, Theodorescu D (January 2007). "Atypical small acinar proliferation: biopsy artefact or distinct pathological entity". BJU International. 99 (4): 780–5\. doi:10.1111/j.1464-410X.2006.06703.x. PMID 17378841. S2CID 30734977. Archived from the original on 2013-01-05.
2. ^ Leite KR, Camara-Lopes LH, Cury J, Dall'oglio MF, Sañudo A, Srougi M (June 2008). "Prostate cancer detection at rebiopsy after an initial benign diagnosis: results using sextant extended prostate biopsy". Clinics. 63 (3): 339–42\. doi:10.1590/S1807-59322008000300009. PMC 2664245. PMID 18568243.
3. ^ Bostwick DG, Meiers I (July 2006). "Atypical small acinar proliferation in the prostate: clinical significance in 2006". Arch. Pathol. Lab. Med. 130 (7): 952–7\. doi:10.5858/2006-130-952-ASAPIT. PMID 16831049.
4. ^ Rubin MA, Bismar TA, Curtis S, Montie JE (July 2004). "Prostate needle biopsy reporting: how are the surgical members of the Society of Urologic Oncology using pathology reports to guide treatment of prostate cancer patients?". Am. J. Surg. Pathol. 28 (7): 946–52\. doi:10.1097/00000478-200407000-00016. PMID 15223967. S2CID 12886636.

## External links

[edit]

Classification|

|

External resources|

* eMedicine: med/3056